The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer
European Urology, ISSN: 0302-2838, Vol: 79, Issue: 4, Page: 437-439
2021
- 3Citations
- 6Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- CrossRef3
- Captures6
- Readers6
Article Description
There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0302283821000014; http://dx.doi.org/10.1016/j.eururo.2021.01.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85099433647&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33454163; https://linkinghub.elsevier.com/retrieve/pii/S0302283821000014; https://dx.doi.org/10.1016/j.eururo.2021.01.001
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know